高 瑛,李 岚,张维华.Notch信号通路对急性B淋巴细胞白血病患者CD4+CD25+CD127dim/-调节性T细胞的调控作用[J].肿瘤学杂志,2022,28(1):46-52. |
Notch信号通路对急性B淋巴细胞白血病患者CD4+CD25+CD127dim/-调节性T细胞的调控作用 |
Modulatory Function of Notch Signaling Pathway to CD4+CD25+CD127dim/- Regulatory T Cells in Patients with B-cell Acute Lymphoblastic Leukemia |
投稿时间:2021-08-05 |
DOI:10.11735/j.issn.1671-170X.2022.01.B009 |
|
|
中文关键词: 急性淋巴细胞白血病 Notch信号通路 调节性T细胞 |
英文关键词:acute lymphoblastic leukemia Notch signaling pathway regulatory T cells |
基金项目:陕西省人民医院科技人才计划项目(2021BJ-26);西安市科技计划项目 [20YXYJ0009(11)];陕西省卫生健康科研基金(2018A005) |
|
摘要点击次数: 1142 |
全文下载次数: 202 |
中文摘要: |
摘 要:[目的] 观察急性B淋巴细胞白血病(B-cell acute lymphoblastic leukemia,B-ALL)患者外周血Notch信号通路分子表达和CD4+CD25+CD127dim/-调节性T细胞(regulatory T cells,Treg)水平,评估Notch信号通路对B-ALL患者Treg活性的影响。 [方法] 入组31例B-ALL患者和20名对照者,分选血浆和外周血单个核细胞(peripheral blood mononuclear cells,PBMC),纯化CD4+CD25+CD127dim/- Treg。实时定量PCR法检测PBMC中Notch1~4、Hes1、Hes5 mRNA相对表达量,流式细胞术检测CD4+CD25+CD127dim/- Treg比例,酶联免疫吸附实验检测血浆白细胞介素10(interleukin-10,IL-10)和IL-35水平。使用Notch信号通路抑制剂GSI刺激B-ALL患者分选的PBMC,检测细胞增殖、Treg比例、IL-10和IL-35表达变化。使用GSI刺激B-ALL患者纯化的Treg,与自体PBMC以1∶10比例共培养,检测细胞增殖、IL-10、IL-35、干扰素-γ水平变化。两组间比较采用独立样本t检验或配对t检验。[结果] B-ALL患者PBMC中Notch受体(包括Notch1、Notch2、Notch3、Notch4)和Notch下游信号分子Hes1、Hes5 mRNA相对表达量均较对照者升高(P<0.001)。B-ALL患者CD4+CD25+CD127dim/- Treg比例高于对照者(8.90%±2.41% vs 4.68%±1.01%,P<0.001)。B-ALL患者外周血IL-10和IL-35水平均高于对照者(P<0.05)。GSI刺激后B-ALL患者PBMC增殖水平与无GSI刺激组差异无统计学意义(P=0.689),但GSI刺激后Treg比例和IL-10、IL-35水平均较无GSI刺激组降低(P<0.05)。使用GSI刺激Treg后与自体PBMC共培养,其抑制PBMC增殖的能力减弱(P<0.001),IL-10和IL-35水平减少(P<0.05),但干扰素-γ水平增加(P<0.001)。[结论] B-ALL患者外周血中Notch受体表达升高可能诱导CD4+CD25+CD127dim/- Treg数量增加和免疫抑制活性增强。 |
英文摘要: |
Abstract:[Objective] To investigate the effect of Notch signaling pathway on CD4+CD25+CD127dim/- regulatory T cell(Treg) levels in patients with B-cell acute lymphoblastic leukemia(B-ALL). [Methods] Thirty-one B-ALL patients and twenty healthy subjects(control group) were enrolled in the study. The peripheral blood mononuclear cells(PBMCs) were isolated and CD4+CD25+CD127dim/- Treg cells were sorted out. The relative expression levels of Notch 1~4, Hes1 and Hes5 mRNA in PBMCs were semi-quantified by RT-PCR. The percentage of CD4+CD25+CD127dim/- Treg was measured by flow cytometry. Plasma interleukin 10(IL-10) and IL-35 was measured by enzyme-linked immunosorbent assay. PBMCs from B-ALL patients were stimulated with Notch signaling inhibitor, then cell proliferation, Treg percentage, IL-10 and IL-35 secretion were investigated. Sorted Treg cells from B-ALL patients were stimulated with GSI, and then were co-cultured with autologous PBMC at the ratio of 1∶10, and cell proliferation, IL-10, IL-35 and interferon-γ expression levels were then assessed. Unpaired t test or paired t test was used for comparison between two groups. [Results] The relative mRNA expression levels of Notch receptors Notch1~4 and Notch signaling downstream molecules(Hes1 and Hes5) were elevated in PBMCs from B-ALL patients compared with in controls(P<0.001). The percentage of CD4+CD25+CD127dim/- Treg cells was increased in B-ALL patients compared with controls(8.90%±2.41% vs 4.68%±1.01%, P<0.001). Plasma IL-10 and IL-35 levels were up-regulated in B-ALL patients compared with in controls(P<0.05). There was no significant difference of cell proliferation between PBMCs with GSI stimulation and without GSI stimulation(P=0.689). However, GSI stimulation reduced Treg percentage as well as IL-10 and IL-35(P<0.05). The inhibitory function to PBMC proliferation was suppressed in response to GSI stimulation(P<0.001). GSI stimulation down-regulated IL-10 and IL-35(P<0.05), while up-regulate interferon-γ expression in the supernatants(P<0.001). [Conclusion] Elevation of circulating Notch receptors in B-ALL patients might induce the increased number of CD4+CD25+CD127dim/- Treg cells and promote immunosuppressive activity. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |